In continuation to the intimation dated August 4, 2023 in relation to initiation of initial public offer (‘IPO’) process, by way of an offer for sale by Agilus Diagnostics (‘Agilus’) of such number of equity shares as may be offered by certain existing and eligible shareholders of Agilus in the IPO, in accordance with applicable laws. In this regard, and pursuant to Regulation 30 of the SEBI Listing Regulations, Fortis Healthcare has informed that Agilus has, on September 29, 2023, filed the draft red herring prospectus (the ‘DRHP’) with the Securities and Exchange Board of India. The actual timing and implementation of the IPO will be subject to the determination of the Company’s and Agilus’s respective boards, after considering the prevailing market conditions and other relevant factors and at such price determined in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, The proposed IPO shall also be subject to such regulatory approvals, as required under applicable law.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7248.75 |
Max Healthcare Inst | 1166.60 |
Narayana Hrudayalay | 1286.30 |
Aster DM Healthcare | 486.85 |
Global Health | 1098.95 |
View more.. |